Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick

    Editors Pick - Page 31

    Fortis investors move SEBI over delay in IHH open offer, ask for interest: Report

    Fortis investors move SEBI over delay in IHH open offer, ask for interest: Report

    Meghna A Singhania23 May 2019 5:22 PM IST
    New Delhi: Displeased with delay in an open offer to buy an additional stake, a few of the shareowners holding minor shares of Fortis Healthcare Ltd...
    CDSCO rejects GSK request to skip Phase III trial for Influenza Vaccine for higher age groups

    CDSCO rejects GSK request to skip Phase III trial for Influenza Vaccine for higher age groups

    Meghna A Singhania22 May 2019 5:25 PM IST
    New Delhi: One of the oldest pharmaceutical and healthcare companies in India, GlaxoSmithKline recently presented before the Subject Expert Committee...
    Drug Alert: CDSCO declares 31 samples as sub-standard in quality in random sampling; Details

    Drug Alert: CDSCO declares 31 samples as sub-standard in quality in random sampling; Details

    Meghna A Singhania21 May 2019 4:44 PM IST
    New Delhi: Apex drug regulatory body, the Central Drugs Standard Control Organization (CDSCO) has declared more than a dozen drugs as sub-standard in...
    Red Flag: CDSCO warns against Medtronic pacemaker for battery related malfunction

    Red Flag: CDSCO warns against Medtronic pacemaker for battery related malfunction

    Meghna A Singhania20 May 2019 4:30 PM IST
    New Delhi: Accounting for the safety efficacy, India’s apex drug regulator Central Drugs Standard Control Organisation (CDSCO) has issued an advisory...
    Setback: Delhi HC restricts Natco Pharma from manufacturing cancer drug Ceritinib

    Setback: Delhi HC restricts Natco Pharma from manufacturing cancer drug Ceritinib

    Meghna A Singhania19 May 2019 11:00 AM IST
    New Delhi: In a major setback to the Hyderabad-based Natco Pharma, the Delhi High Court has passed an interim order barring the company from...
    CDSCO releases Risk classification of newly notified Medical Devices, IVDs; Details

    CDSCO releases Risk classification of newly notified Medical Devices, IVDs; Details

    Meghna A Singhania18 May 2019 2:08 PM IST
    New Delhi: Through a recent notification, country's central medical device regulator, the Central Drugs Standards Control Organization (CDSCO) has...
    Its All In The Name: State drug regulators told to BAN marketing of new formulations in old brand names

    Its All In The Name: State drug regulators told to BAN marketing of new formulations in old brand names

    Farhat Nasim17 May 2019 5:37 PM IST
    New Delhi: In a major setback to many pharma companies in the country, the ruling Government is reported to have directed state drug controllers to...
    NPPA strikes again on anti-cancer drug prices; Details

    NPPA strikes again on anti-cancer drug prices; Details

    Meghna A Singhania16 May 2019 4:38 PM IST
    New Delhi: Through a recent Office Memorandum, the National Pharmaceutical Pricing Authority (NPPA) has released an additional list of 9 brands under...
    SEBI asks Fortis to recover Rs 403 crore from Singh Brothers; FHL informs HC

    SEBI asks Fortis to recover Rs 403 crore from Singh Brothers; FHL informs HC

    Meghna A Singhania15 May 2019 12:20 PM IST
    Fortis made the submission in a recent affidavit filed in an ongoing case by Japanese drugmaker Daiichi Sankyo against the Singh brothers and their...
    Inflated prices to 1000 per cent; Lupin, Sun Pharma, Dr Reddys, others face lawsuit

    Inflated prices to 1000 per cent; Lupin, Sun Pharma, Dr Reddys, others face lawsuit

    Farhat Nasim14 May 2019 4:57 PM IST
    Mumbai: In a major setback, a group of domestic pharmaceutical companies including Zydus Cadila, Lupin, Aurobindo Pharma, Dr Reddy's Labs, Wockhardt,...
    JnJ baby shampoo on attack; gets BANNED in Uttar Pradesh

    JnJ baby shampoo on attack; gets BANNED in Uttar Pradesh

    Farhat Nasim13 May 2019 10:35 AM IST
    New Delhi: Notable pharmaceutical firm Johnson and Johnson (JnJ) is in a soup as its popular baby shampoo has been banned in Uttar Pradesh. According...
    As e-pharmacies battle regulatory issues, Netmeds reported to be in talks to raise funds over Rs 698 crore

    As e-pharmacies battle regulatory issues, Netmeds reported to be in talks to raise funds over Rs 698 crore

    Garima12 May 2019 1:37 PM IST
    New Delhi: Despite regulatory objections being raised over the practice of online pharmacy, the faith of the investment community in the future of...
    PrevNext

    Popular Stories

    India should become self-reliant in medical equipment, devices: Kasturirangan

    India should become self-reliant in medical equipment, devices: Kasturirangan

    Lupin gets USFDA EIR for Nagpur Facility

    Lupin gets USFDA EIR for Nagpur Facility

    Indira IVF to invest Rs 80 crore to expand presence in south India by 2020

    Indira IVF to invest Rs 80 crore to expand presence in south India by 2020

    Shipment of  antimalarial drug to US is likely to start next week: Indian Pharmaceutical Alliance

    Shipment of antimalarial drug to US is likely to start next week: Indian Pharmaceutical Alliance

    Lasa Supergenerics gets FDA nod for Progesterone

    Lasa Supergenerics gets FDA nod for Progesterone

    Wellthy Therapeutics announces Rs 30 crore financing round led by Saama Capital

    Wellthy Therapeutics announces Rs 30 crore financing round led by Saama Capital

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok